Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes
Open Access
- 14 September 2010
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (12) , 2635-2641
- https://doi.org/10.2337/dc10-0616
Abstract
OBJECTIVE: To describe the sensitivity, specificity, positive predictive value, and negative predictive value of vibration perception threshold (VPT) testing in subjects with type 1 diabetes relative to gold standard assessments of peripheral neuropathy. RESEARCH DESIGN AND METHODS: VPT was determined in 1,177 adults with type 1 diabetes 13–14 years after participating in a study of intensive (INT) versus conventional (CONV) diabetes treatment. Abnormal VPT was defined by values exceeding 2.5 SD above age-specific normal values. Signs and symptoms of peripheral neuropathy were assessed and electrodiagnostic studies were performed to establish definite clinical neuropathy, abnormal nerve conduction, and confirmed clinical neuropathy (the presence of both definite clinical neuropathy and abnormal nerve conduction). RESULTS: Thirty-seven percent of subjects had definite clinical neuropathy, 61% had abnormal nerve conduction, and 30% had confirmed clinical neuropathy. Abnormal VPT was more common among former CONV than among INT subjects (64 vs. 57%, P < 0.05) and was associated with older age. VPT was a sensitive measure of confirmed clinical neuropathy (87%) and of definite clinical neuropathy (80%) and a specific measure of abnormal nerve conduction (62%). Higher VPT cut points improved test sensitivity and lower cut points improved specificity. Areas under the receiver operating characteristic curves ranged from 0.71–0.83 and were higher for older than for younger subjects and highest for those with confirmed clinical neuropathy. CONCLUSIONS: VPT was a sensitive measure of peripheral neuropathy. Future researchers may choose to select VPT cut points for defining abnormality based on the population studied and clinical outcome of interest.This publication has 24 references indexed in Scilit:
- Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyDiabetes Care, 2010
- Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk FactorsDiabetes Care, 2009
- A Comparison of the New Indicator Test for Sudomotor Function (Neuropad®) with the Vibration Perception Threshold and the Clinical Examination in the Diagnosis of Peripheral Neuropathy in Subjects with Type 2 DiabetesExperimental and Clinical Endocrinology & Diabetes, 2007
- Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial CompletionDiabetes Care, 2007
- Technology literature review: Quantitative sensory testingMuscle & Nerve, 2004
- Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trialAnnals of Neurology, 1995
- The Prediction of Diabetic Neuropathic Foot Ulceration Using Vibration Perception Thresholds: A prospective studyDiabetes Care, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Sensory testing versus nerve conduction velocity in diabetic polyneuropathyMuscle & Nerve, 1992
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960